Results 171 to 180 of about 1,179,909 (205)
Some of the next articles are maybe not open access.

Effect of Induced Infarction on Rat Liver Implanted with Walker Carcinoma 256

Archives of Surgery, 1959
Ligation of a branch of the portal vein or of an extrahepatic bile duct results in atrophy of the corresponding liver lobe. The remaining liver undergoes compensatory hypertrophy. This process is well tolerated by rabbits and dogs.1,4,5Complete devascularization of a portion of the liver results in infarction.
G E, KRAUS, A, BELTRAN
openaire   +2 more sources

Inhibition of Walker 256 Intramuscular Carcinoma in Rats by Administration of Hydrazine Sulfate

Oncology, 2009
Hydrazine sulfate was found to be a potent inhibitor of the Waker 256 intramuscular carcinoma in rats. In dosages ranging from 4 mg/kg to 128 mg/kg rat body weight, the tumor inhibitions ranged from 28% to 94%, respectively. Only at a dose, of 128 mg/kg was there any drug-induced mortality; there was indication of drug-induced weight loss at the 64 mg ...
openaire   +2 more sources

Inhibition of Walker 256 Intramuscular Carcinoma in Rats by Administration of L-Tryptophan

Oncology, 2009
L-tryptophan was found to consistently inhibit in vivo growth of the Walker 256 intramuscular carcinoma in rats. Doses of 8, 4 and 2 mM/kg body weight of L-tryptophan inhibited the tumor approximately 55%, 50% and 35%, respectively, the inhibitions being statistically significant.
openaire   +2 more sources

An interdisciplinary consensus on the management of brain metastases in patients with renal cell carcinoma

Ca-A Cancer Journal for Clinicians, 2022
Marion Smits   +2 more
exaly  

Ischemia-reperfusion of Walker 256 carcinoma

2001
Martinac, Pero   +5 more
openaire   +3 more sources

Effect of dihydroxyanthraquinone on the response of walker 256 carcinoma to radiation

International Journal of Radiation Oncology*Biology*Physics, 1981
Eashwer K. Reddy   +4 more
openaire   +1 more source

Oral cavity and oropharyngeal squamous cell carcinoma—an update

Ca-A Cancer Journal for Clinicians, 2015
Angela Chi
exaly  

Treatment of renal cell carcinoma: Current status and future directions

Ca-A Cancer Journal for Clinicians, 2017
Pedro C Barata
exaly  

Home - About - Disclaimer - Privacy